학술논문

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Document Type
Academic Journal
Source
Cancer Chemotherapy & Pharmacology (CANCER CHEMOTHER PHARMACOL), Feb2015; 75(2): 343-352. (10p)
Subject
Language
English
ISSN
0344-5704